178 related articles for article (PubMed ID: 11370075)
1. [Prostate cancer and medical ethics].
Saksela E
Duodecim; 1997; 113(6):532-6; author reply 536-9. PubMed ID: 11370075
[No Abstract] [Full Text] [Related]
2. Prostate cancer.
Harris M
Aust Fam Physician; 2003 Jun; 32(6):395. PubMed ID: 12833759
[No Abstract] [Full Text] [Related]
3. [About Psa-screening].
Hakama M; Auvinen A; Stenman UH; Tammela T
Duodecim; 1996; 112(14):1314-6. PubMed ID: 10596108
[No Abstract] [Full Text] [Related]
4. [Prostate cancer screening].
Saksela E
Duodecim; 1997; 113(9):871. PubMed ID: 11466912
[No Abstract] [Full Text] [Related]
5. PSA testing.
Frydenberg M
Aust Fam Physician; 2003 Jun; 32(6):396. PubMed ID: 12833760
[No Abstract] [Full Text] [Related]
6. Contemporary view of prostate cancer diagnosis and treatment.
Costello AJ
Aust Fam Physician; 2003 Jun; 32(6):396-8. PubMed ID: 12833761
[No Abstract] [Full Text] [Related]
7. Testing for prostate cancer. A consumer view.
Gardner M
Aust Fam Physician; 2003 Jun; 32(6):398-9. PubMed ID: 12833762
[No Abstract] [Full Text] [Related]
8. Prostate-specific antigen screening for prostate cancer: a decision-analytical perspective.
Hayes JH; Barry MJ; Kantoff PW; Stahl JE
BJU Int; 2007 Sep; 100(3):486-8. PubMed ID: 17669139
[No Abstract] [Full Text] [Related]
9. Patient education. Prostate cancer.
Frydenberg M
Aust Fam Physician; 2003 Jun; 32(6):428. PubMed ID: 12833768
[No Abstract] [Full Text] [Related]
10. Is the era of prostate-specific antigen over?
Djavan B; Rocco B; Stangelberger A; De Cobelli O; Marberger M
BJU Int; 2007 Jul; 100 Suppl 2():8-10. PubMed ID: 17594349
[No Abstract] [Full Text] [Related]
11. The controversy over PSA testing: has anything changed?
Johns Hopkins Med Lett Health After 50; 2009 Aug; 21(6):1-2. PubMed ID: 19722309
[No Abstract] [Full Text] [Related]
12. Improving appropriateness of prostate-specific antigen screening.
Lippi G; Montagnana M; Guidi GC
Arch Intern Med; 2007 Dec; 167(22):2529-30. PubMed ID: 18071182
[No Abstract] [Full Text] [Related]
13. Screening for prostate cancer: recommendations and rationale.
Berg AO;
Am J Nurs; 2003 Mar; 103(3):107-10; discussion 111. PubMed ID: 12626949
[No Abstract] [Full Text] [Related]
14. Prostate carcinoma: clarification through clinical insight and molecular diagnostics.
Meyers FJ; DeVere White RW
West J Med; 1998 Jun; 168(6):525. PubMed ID: 9655997
[No Abstract] [Full Text] [Related]
15. Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
Schröder FH
Can J Urol; 2005 Feb; 12 Suppl 1():2-6; discussion 92-3. PubMed ID: 15780157
[TBL] [Abstract][Full Text] [Related]
16. Screening for prostate cancer: updated experience from the Tyrol study.
Horninger W; Berger A; Pelzer A; Klocker H; Oberaigner W; Schönitzer D; Severi G; Robertson C; Boyle P; Bartsch G
Can J Urol; 2005 Feb; 12 Suppl 1():7-13; discussion 92-3. PubMed ID: 15780158
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
[TBL] [Abstract][Full Text] [Related]
18. [Screening with PSA (Prostate Specific Antigen) raises ethical questions].
Taube A
Lakartidningen; 1996 Sep; 93(39):3341. PubMed ID: 8926796
[No Abstract] [Full Text] [Related]
19. Prostate-specific antigen assay using whole blood samples spotted on filter paper and its application to mass screening for prostate cancer.
Nanri M; Nanri K; Fujiyama C; Tokuda Y; Nakamura K; Uozumi J
Int J Urol; 2007 Jun; 14(6):505-9. PubMed ID: 17593094
[TBL] [Abstract][Full Text] [Related]
20. Patient education. PSA: pros and cons.
Gattellari M; Ward JE
Aust Fam Physician; 2003 Jun; 32(6):429-30. PubMed ID: 12833769
[No Abstract] [Full Text] [Related]
[Next] [New Search]
